Compare GTY & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GTY | BHC |
|---|---|---|
| Founded | 1955 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.0B |
| IPO Year | 1998 | 1996 |
| Metric | GTY | BHC |
|---|---|---|
| Price | $32.69 | $6.33 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 5 | 3 |
| Target Price | ★ $32.60 | $8.00 |
| AVG Volume (30 Days) | 454.6K | ★ 4.9M |
| Earning Date | 04-22-2026 | 04-29-2026 |
| Dividend Yield | ★ 5.92% | N/A |
| EPS Growth | 8.00 | ★ 423.08 |
| EPS | ★ 0.79 | N/A |
| Revenue | $221,727,000.00 | ★ $8,724,000,000.00 |
| Revenue This Year | $9.39 | $4.61 |
| Revenue Next Year | $7.83 | N/A |
| P/E Ratio | $42.27 | ★ N/A |
| Revenue Growth | ★ 9.02 | N/A |
| 52 Week Low | $25.39 | $4.33 |
| 52 Week High | $36.83 | $8.69 |
| Indicator | GTY | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 33.13 | 63.27 |
| Support Level | $32.11 | $5.89 |
| Resistance Level | $34.33 | $7.34 |
| Average True Range (ATR) | 0.81 | 0.43 |
| MACD | -0.30 | 0.13 |
| Stochastic Oscillator | 0.60 | 66.61 |
Getty Realty Corp is a net lease real estate investment trust in the U.S.A, specializing in the acquisition, financing, and development of convenience, automotive, and other single-tenant retail real estate. The company's portfolio includes convenience stores, express tunnel car washes, automotive service centers (gasoline and repair, oil and maintenance, tire and battery, and collision), drive-thru quick service restaurants, and certain other freestanding retail properties. It generates maximum revenue in the form of rental income.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.